ID   COLO 857
AC   CVCL_2004
SY   COLO-857; Colo 857; COLO857; Colorado 857
DR   CLO; CLO_0002568
DR   EFO; EFO_0006381
DR   CLDB; cl861
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472866
DR   cancercelllines; CVCL_2004
DR   Cosmic; 972258
DR   ECACC; 93051120
DR   EGA; EGAS00001000610
DR   GEO; GSM827425
DR   LINCS_LDP; LCL-1241
DR   PharmacoDB; COLO857_220_2019
DR   Progenetix; CVCL_2004
DR   Wikidata; Q54814170
RX   PubMed=7780963;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   Population: Caucasian.
CC   HLA typing: A*01:01,01:01; B*40:02,40:02; C*03:04,03:04 (PubMed=26589293).
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): ECACC; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 9
ST   Penta E: 7,12
ST   TH01: 10
ST   TPOX: 8,11
ST   vWA: 17,18,19 (PubMed=25877200)
ST   vWA: 17,19 (ECACC)
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1137 ! COLO 829
OI   CVCL_1999 ! COLO 829BL
OI   CVCL_L503 ! COLO 831
OI   CVCL_2000 ! COLO 832
OI   CVCL_L504 ! COLO 833
OI   CVCL_L505 ! COLO 834
OI   CVCL_L506 ! COLO 835
OI   CVCL_L507 ! COLO 838
OI   CVCL_2001 ! COLO 839
OI   CVCL_L508 ! COLO 845
OI   CVCL_L509 ! COLO 848
OI   CVCL_2002 ! COLO 849
OI   CVCL_2003 ! COLO 853
OI   CVCL_2005 ! COLO 858
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 23
//
RX   PubMed=7780963;
RA   Easty D.J., Guthrie B.A., Maung K., Farr C.J., Lindberg R.A.,
RA   Toso R.J., Herlyn M., Bennett D.C.;
RT   "Protein B61 as a new growth factor: expression of B61 and
RT   up-regulation of its receptor epithelial cell kinase during melanoma
RT   progression.";
RL   Cancer Res. 55:2528-2532(1995).
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458;
RA   Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P.,
RA   Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J.,
RA   Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C.,
RA   Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J.,
RA   Haber D.A.;
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//
RX   PubMed=25485619; DOI=10.1038/nbt.3080;
RA   Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S.,
RA   Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G.,
RA   Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J.,
RA   Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L.,
RA   Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J.,
RA   Settleman J., Seshagiri S., Zhang Z.-M.;
RT   "A comprehensive transcriptional portrait of human cancer cell
RT   lines.";
RL   Nat. Biotechnol. 33:306-312(2015).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=26589293; DOI=10.1186/s13073-015-0240-5;
RA   Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P.,
RA   Loewer M., Sahin U., Castle J.C.;
RT   "TCLP: an online cancer cell line catalogue integrating HLA type,
RT   predicted neo-epitopes, virus and gene expression.";
RL   Genome Med. 7:118.1-118.7(2015).
//